Table 1 Characteristics of COVID-19 patients admitted in the ICU, according to the French administrative region, March, 1st to May, 31st 2020

Patient in ICU—all causes (n)

58,033

6942

2235

2166

1831

202

5500

Critically ill COVID-19 patients in ICU (n, %)

14,513

25.0%

1358

19.6%

580

26.0%

256

11.8%

410

22.4%

44

21.8%

2130

38.7%

Age class (n, %)

 < 65 y.o

7145

49.2%

521

38.4%

213

36.7%

110

43.0%

182

44.4%

14

31.8%

928

43.6%

 65–79 y.o

6280

43.3%

698

51.4%

299

51.6%

129

50.4%

196

47.8%

25

56.8%

1066

50.0%

 ≥ 80 y.o

1088

7.5%

139

10.2%

68

11.7%

17

6.6%

32

7.8%

5

11.4%

136

6.4%

Age (mean ± s.d.)

63 ± 13

65.9 ± 12.4

66.9 ± 11.5

63.4 ± 13.3

64.2 ± 12.6

67.2 ± 13.2

64.4 ± 11.9

Sex ratio (M/F)

2.5

2.7

2.3

2.4

2.3

2.4

2.6

SAPS II (mean ± s.d.)

39.47 ± 17

38.85 ± 16.1

41.46 ± 15.6

37.69 ± 16.6

37.73 ± 15.9

39.91 ± 15.3

42.09 ± 17.4

Comorbidities (n, %)

11,739

80.9%

1132

83.4%

494

85.2%

196

76.6%

356

86.8%

33

75.0%

1782

83.7%

 High blood pressure

7131

49.1%

695

51.2%

293

50.5%

122

47.7%

229

55.9%

16

36.4%

1158

54.4%

 Chronic heart disease

4971

34.3%

545

40.1%

243

41.9%

84

32.8%

157

38.3%

14

31.8%

893

41.9%

 Diabetes

4487

30.9%

447

32.9%

189

32.6%

73

28.5%

150

36.6%

8

18.2%

667

31.3%

 Obesity

3549

24.5%

328

24.2%

139

24.0%

59

23.0%

129

31.5%

5

11.4%

563

26.4%

 Cancer

3078

21.2%

370

27.2%

174

30.0%

64

25.0%

128

31.2%

14

31.8%

567

26.6%

 Chronic renal disease

2352

16.2%

310

22.8%

93

16.0%

46

18.0%

84

20.5%

4

9.1%

448

21.0%

 Chronic pulmonary disease

1913

13.2%

218

16.1%

96

16.6%

34

13.3%

75

18.3%

6

13.6%

319

15.0%

 Neurological disease

1120

7.7%

166

12.2%

64

11.0%

12

4.7%

33

8.0%

2

4.5%

204

9.6%

 Chronic liver disease

1046

7.2%

102

7.5%

41

7.1%

16

6.3%

35

8.5%

1

2.3%

184

8.6%

ICU specific care supports (n, %)

 Central venous catheter

7407

51.0%

697

51.3%

258

44.5%

137

53.5%

215

52.4%

25

56.8%

1389

65.2%

 Continuous hemodynamic monitoring

7601

52.4%

774

57.0%

225

38.8%

114

44.5%

238

58.0%

30

68.2%

1319

61.9%

 Vasoactive treatment*

8528

58.8%

772

56.8%

367

63.3%

142

55.5%

230

56.1%

16

36.4%

1438

67.5%

  Renal replacement therapy

2165

14.9%

212

15.6%

64

11.0%

31

12.1%

49

12.0%

3

6.8%

259

12.2%

  ECMO

587

4.0%

25

1.8%

13

2.2%

6

2.3%

13

3.2%

2

4.5%

82

3.8%

Mechanical ventilation** (n, %)

 Non invasive/high flow oxygenotherapy

6546

45.1%

664

48.9%

241

41.6%

105

41.0%

191

46.6%

16

36.4%

824

38.7%

 Invasive

9885

68.1%

866

63.8%

430

74.1%

165

64.5%

276

67.3%

21

47.7%

1,652

77.6%

 Invasive with prone position

5534

38.1%

534

39.3%

257

44.3%

101

39.5%

165

40.2%

14

31.8%

967

45.4%

Death (n, %)

4256

29.3%

347

25.6%

175

30.2%

45

17.6%

87

21.2%

12

27.3%

660

31.0%

Patient in ICU—all causes (n)

5464

13,620

2451

4833

5142

2964

4683

Critically ill COVID-19 patients in ICU (n, %)

1333

24.4%

5650

41.5%

387

15.8%

503

10.4%

667

13.0%

355

12.0%

840

17.9%

Age class (n, %)

 < 65 y.o

624

46.8%

3321

58.8%

177

45.7%

248

49.3%

286

42.9%

170

47.9%

351

41.8%

 65–79 y.o

579

43.4%

2016

35.7%

180

46.5%

212

42.1%

318

47.7%

166

46.8%

396

47.1%

 ≥ 80 y.o

130

9.8%

313

5.5%

30

7.8%

43

8.5%

63

9.4%

19

5.4%

93

11.1%

Age (mean ± s.d.)

63.9 ± 12.9

61 ± 13.2

63.6 ± 12.2

63.7 ± 12.6

64.2 ± 13.3

62.4 ± 13.2

65.3 ± 13.2

Sex ratio (M/F)

2.3

2.6

2.4

2.5

2.3

2.7

2.3

SAPS II (mean ± s.d.)

41.79 ± 18.6

38.76 ± 17.2

36.81 ± 14.8

39.5 ± 18.2

37.19 ± 16.1

35.95 ± 15.3

39.27 ± 15.6

Comorbidities (n, %)

1151

86.3%

4364

77.2%

326

84.2%

403

80.1%

537

80.5%

285

80.3%

680

81.0%

 High blood pressure

740

55.5%

2571

45.5%

207

53.5%

236

46.9%

306

45.9%

154

43.4%

404

48.1%

 Chronic heart disease

524

39.3%

1505

26.6%

140

36.2%

199

39.6%

245

36.7%

99

27.9%

323

38.5%

 Diabetes

413

31.0%

1746

30.9%

115

29.7%

135

26.8%

187

28.0%

87

24.5%

270

32.1%

 Obesity

358

26.9%

1286

22.8%

117

30.2%

121

24.1%

165

24.7%

88

24.8%

191

22.7%

 Cancer

420

31.5%

666

11.8%

78

20.2%

116

23.1%

186

27.9%

82

23.1%

213

25.4%

 Chronic renal disease

266

20.0%

627

11.1%

57

14.7%

85

16.9%

139

20.8%

51

14.4%

142

16.9%

 Chronic pulmonary disease

209

15.7%

535

9.5%

55

14.2%

82

16.3%

110

16.5%

34

9.6%

140

16.7%

 Neurological disease

102

7.7%

301

5.3%

16

4.1%

60

11.9%

75

11.2%

26

7.3%

59

7.0%

 Chronic liver disease

130

9.8%

352

6.2%

21

5.4%

31

6.2%

52

7.8%

22

6.2%

59

7.0%

ICU specific care supports (n, %)

 Central venous catheter

695

52.1%

2700

47.8%

197

50.9%

284

56.5%

322

48.3%

161

45.4%

327

38.9%

 Continuous hemodynamic monitoring

799

59.9%

2726

48.2%

198

51.2%

318

63.2%

368

55.2%

144

40.6%

348

41.4%

 Vasoactive treatment*

746

56.0%

3234

57.2%

243

62.8%

315

62.6%

369

55.3%

192

54.1%

464

55.2%

Renal replacement therapy

212

15.9%

1007

17.8%

50

12.9%

57

11.3%

77

11.5%

46

13.0%

98

11.7%

ECMO

52

3.9%

306

5.4%

10

2.6%

7

1.4%

17

2.5%

20

5.6%

34

4.0%

Mechanical ventilation** (n, %)

 Non invasive/high flow oxygenotherapy

696

52.2%

2450

43.4%

229

59.2%

229

45.5%

339

50.8%

99

27.9%

463

55.1%

 Invasive

849

63.7%

3823

67.7%

278

71.8%

334

66.4%

419

62.8%

242

68.2%

530

63.1%

 Invasive with prone position

389

29.2%

2158

38.2%

143

37%

143

28.4%

224

33.6%

137

38.6%

302

36.0%

Death (n, %)

406

30.5%

1894

33.5%

98

25.3%

93

18.5%

151

22.6%

80

22.5%

208

24.8%